Development of Burkholderia mallei and pseudomallei vaccines

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue MAR, 2013, Pages

  Silva, Ediane B ^a   Dow, Steven W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Burkholderia; Glanders; Immune response; Live attenuated; Melioidosis; Vaccine

Indexed keywords

ABC TRANSPORTER; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; BIPD PROTEIN; BURKHOLDERIA VACCINE; CASPASE; FLAGELLIN; GAMMA INTERFERON; HCP1 PROTEIN; HCP2 PROTEIN; HCP3 PROTEIN; HCP6 PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VACCINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVE VACCINE; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 85; SUBUNIT VACCINE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; BACTERIAL ANTIGEN; VACCINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BACTERIUM MUTANT; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; DRUG TARGETING; GLANDERS; HUMAN; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MELIOIDOSIS; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; QUORUM SENSING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TYPE III SECRETION SYSTEM; TYPE IV SECRETION SYSTEM; ANIMAL; BURKHOLDERIA; DRUG DEVELOPMENT; IMMUNE RESPONSE; IMMUNOLOGY; LIVE ATTENUATED;

BURKHOLDERIA; GLANDERS; IMMUNE RESPONSE; LIVE ATTENUATED; MELIOIDOSIS; VACCINE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; DRUG DISCOVERY; GLANDERS; HUMANS; MELIOIDOSIS; VACCINES, ATTENUATED; VACCINES, SUBUNIT;

EID: 84883046189     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2013.00010     Document Type: Review

References (124)

1. Allwood, E. M., Devenish, R. J., Prescott, M., Adler, B., and Boyce, J. D. (2011). Strategies for intracellular survival of Burkholderia pseudomallei. Front. Microbiol. 2:170. doi: 10.3389/fmicb.2011.00170
2. Amemiya, K. (2002). Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice. Infect. Immun. 70, 2319-2325.
3. Anuntagool, N., and Sirisinha, S. (2002). Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Microbiol. Immunol. 46, 143-150.
4. Atkins, T., Prior, R., Mack, K., Russell, P., Nelson, M., Prior, J., et al. (2002a). Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J. Med. Microbiol. 51, 539-547.
5. Atkins, T., Prior, R. G., Mack, K., Russell, P., Nelson, M., Oyston, P. C., et al. (2002b). A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70, 5290-5294.
6. Aucoin, D. P., Reed, D. E., Marlenee, N. L., Bowen, R. A., Thorkildson, P., Judy, B. M., et al. (2012). Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. PLoS ONE 7:e35386. doi: 10.1371/journal.pone.0035386
7. Bandara, A. B., Deshazer, D., Inzana, T. J., Sriranganathan, N., Schurig, G. G., and Boyle, S. M. (2008). A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice. Microb. Pathog. 45, 207-216.
8. Barnes, J. L., and Ketheesan, N. (2005). Route of infection in melioidosis. Emerging Infect. Dis. 11, 638-639.
9. Barnes, J. L., and Ketheesan, N. (2007). Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Immunol. Cell Biol. 85, 551-557.
10. Barnes, J. L., Williams, N. L., and Ketheesan, N. (2008). Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2). FEMS Immunol. Med. Microbiol. 52, 379-388.
11. Blancou, J. (1994). Early methods for the surveillance and control of glanders in Europe. Rev. Sci. Tech. 13, 545-557.
12. Bottex, C., Gauthier, Y. P., Hagen, R. M., Finke, E. J., Splettstosser, W. D., Thibault, F. M., et al. (2005). Attempted passive prophylaxis with a monoclonal anti-Burkholderia pseudomallei exopolysaccharide antibody in a murine model of melioidosis. Immunopharmacol. Immunotoxicol. 27, 565-583.
13. Breitbach, K., Klocke, S., Tschernig, T., Van Rooijen, N., Baumann, U., and Steinmetz, I. (2006). Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect. Immun. 74, 6300-6309.
14. Breitbach, K., Kohler, J., and Steinmetz, I. (2008). Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1), S89-S94.
15. Breitbach, K., Sun, G. W., Kohler, J., Eske, K., Wongprompitak, P., Tan, G., et al. (2009). Caspase-1 mediates resistance in murine melioidosis. Infect. Immun. 77, 1589-1595.
16. Breitbach, K., Wongprompitak, P., and Steinmetz, I. (2011). Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol. 12:20. doi: 10.1186/1471-2172-12-20
17. Brett, P. J., Mah, D. C., and Woods, D. E. (1994). Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect. Immun. 62, 1914-1919.
18. Bryan, L. E., Wong, S., Woods, D. E., Dance, D. A., and Chaowagul, W. (1994). Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can. J. Infect. Dis. 5, 170-178.
19. Burtnick, M. N., Brett, P. J., Harding, S. V., Ngugi, S. A., Ribot, W. J., Chantratita, N., et al. (2011). The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect. Immun. 79, 1512-1525.
20. Burtnick, M. N., Brett, P. J., Nair, V., Warawa, J. M., Woods, D. E., and Gherardini, F. C. (2008). Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect. Immun. 76, 2991-3000.
21. Ceballos-Olvera, I., Sahoo, M., Miller, M. A., Del Barrio, L., and Re, F. (2011). Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog. 7:e1002452. doi: 10.1371/journal.ppat.1002452
22. Chanchamroen, S., Kewcharoenwong, C., Susaengrat, W., Ato, M., and Lertmemongkolchai, G. (2009). Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect. Immun. 77, 456-463.
23. Chaowagul, W., White, N. J., Dance, D. A., Wattanagoon, Y., Naigowit, P., Davis, T. M., et al. (1989). Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159, 890-899.
24. Charuchaimontri, C., Suputtamongkol, Y., Nilakul, C., Chaowagul, W., Chetchotisakd, P., Lertpatanasuwun, N., et al. (1999). Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29, 813-818.
25. Chen, Y. S., Hsiao, Y. S., Lin, H. H., Liu, Y., and Chen, Y. L. (2006). CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect. Immun. 74, 1699-1705.
26. Cheng, A. C., and Currie, B. J. (2005). Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18, 383-416.
27. Chenthamarakshan, V., Vadivelu, J., and Puthucheary, S. D. (2001). Detection of immunoglobulins M and G using culture filtrate antigen of Burkholderia pseudomallei. Diagn. Microbiol. Infect. Dis. 39, 1-7.
28. Chua, K. L., Chan, Y. Y., and Gan, Y. H. (2003). Flagella are virulence determinants of Burkholderia pseudomallei. Infect. Immun. 71, 1622-1629.
29. Cuccui, J., Easton, A., Chu, K. K., Bancroft, G. J., Oyston, P. C., Titball, R. W., et al. (2007). Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect. Immun. 75, 1186-1195.
30. Currie, B. J., Dance, D. A., and Cheng, A. C. (2008). The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1), S1-S4.
31. Currie, B. J., and Jacups, S. P. (2003). Intensity of rainfall and severity of melioidosis, Australia. Emerging Infect. Dis. 9, 1538-1542.
32. Dance, D. A. (2002). Melioidosis. Curr. Opin. Infect. Dis. 15, 127-132.
33. Deshazer, D., Brett, P. J., Carlyon, R., and Woods, D. E. (1997). Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J. Bacteriol. 179, 2116-2125.
34. Deshazer, D., Brett, P. J., and Woods, D. E. (1998). The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 30, 1081-1100.
35. Detmers, F. J., Lanfermeijer, F. C., and Poolman, B. (2001). Peptides and ATP binding cassette peptide transporters. Res. Microbiol. 152, 245-258.
36. Druar, C., Yu, F., Barnes, J. L., Okinaka, R. T., Chantratita, N., Beg, S., et al. (2008). Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. FEMS Immunol. Med. Microbiol. 52, 78-87.
37. Dvorak, G. D., and Spickler, A. R. (2008). Glanders. J. Am. Vet. Med. Assoc. 233, 570-577.
38. Easton, A., Haque, A., Chu, K., Lukaszewski, R., and Bancroft, G. J. (2007). A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 195, 99-107.
39. Eberl, L. (2006). Quorum sensing in the genus Burkholderia. Int. J. Med. Microbiol. 296, 103-110.
40. Elvin, S. J., Healey, G. D., Westwood, A., Knight, S. C., Eyles, J. E., and Williamson, E. D. (2006). Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect. Immun. 74, 1706-1711.
41. Foulongne, V., Walravens, K., Bourg, G., Boschiroli, M. L., Godfroid, J., Ramuz, M., et al. (2001). Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. Infect. Immun. 69, 547-550.
42. Fritz, D. L., Vogel, P., Brown, D. R., and Waag, D. M. (1999). The hamster model of intraperitoneal Burkholderia mallei (glanders). Vet. Pathol. 36, 276-291.
43. Gilad, J., Harary, I., Dushnitsky, T., Schwartz, D., and Amsalem, Y. (2007). Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness. Isr. Med. Assoc. J. 9, 499-503.
44. Goodyear, A., Bielefeldt-Ohmann, H., Schweizer, H., and Dow, S. (2012a). Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS ONE 7:e37324. doi: 10.1371/journal.pone.0037324
45. Goodyear, A., Troyer, R., Bielefeldt-Ohmann, H., and Dow, S. (2012b). MyD88-dependent recruitment of monocytes and dendritic cells required for protection from pulmonary Burkholderia mallei infection. Infect. Immun. 80, 110-120.
46. Goodyear, A., Jones, A., Troyer, R., Bielefeldt-Ohmann, H., and Dow, S. (2010). Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection. J. Immunol. 184, 1445-1454.
47. Goodyear, A., Kellihan, L., Bielefeldt-Ohmann, H., Troyer, R., Propst, K., and Dow, S. (2009). Protection from pneumonic infection with Burkholderia species by inhalational immunotherapy. Infect. Immun. 77, 1579-1588.
48. Haque, A., Chu, K., Easton, A., Stevens, M. P., Galyov, E. E., Atkins, T., et al. (2006a). A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J. Infect. Dis. 194, 1241-1248.
49. Haque, A., Easton, A., Smith, D., O'Garra, A., Van Rooijen, N., Lertmemongkolchai, G., et al. (2006b). Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 193, 370-379.
50. Hara, Y., Mohamed, R., and Nathan, S. (2009). Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS ONE 4:e6496. doi: 10.1371/journal.pone.0006496
51. Harding, S. V., Sarkar-Tyson, M., Smither, S. J., Atkins, T. P., Oyston, P. C., Brown, K. A., et al. (2007). The identification of surface proteins of Burkholderia pseudomallei. Vaccine 25, 2664-2672.
52. Harland, D. N., Chu, K., Haque, A., Nelson, M., Walker, N. J., Sarkar-Tyson, M., et al. (2007). Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Infect. Immun. 75, 4173-4180.
53. Harley, V. S., Dance, D. A., Drasar, B. S., and Tovey, G. (1998). Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96, 71-93.
54. Healey, G. D., Elvin, S. J., Morton, M., and Williamson, E. D. (2005). Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect. Immun. 73, 5945-5951.
55. Henderson, A., Propst, K., Kedl, R., and Dow, S. (2011). Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. Vaccine 29, 5304-5312.
56. Hii, C. S., Sun, G. W., Goh, J. W., Lu, J., Stevens, M. P., and Gan, Y. H. (2008). Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J. Infect. Dis. 197, 1537-1547.
57. Ho, M., Schollaardt, T., Smith, M. D., Perry, M. B., Brett, P. J., Chaowagul, W., et al. (1997). Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65, 3648-3653.
58. Hodgson, K. A., Morris, J. L., Feterl, M. L., Govan, B. L., and Ketheesan, N. (2011). Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect. 13, 1177-1184.
59. Jones, A. L., Beveridge, T. J., and Woods, D. E. (1996). Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64, 782-790.
60. Jones, S. M., Ellis, J. F., Russell, P., Griffin, K. F., and Oyston, P. C. (2002). Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J. Med. Microbiol. 51, 1055-1062.
61. Ko, W. C., Cheung, B. M., Tang, H. J., Shih, H. I., Lau, Y. J., Wang, L. R., et al. (2007). Melioidosis outbreak after typhoon, southern Taiwan. Emerging Infect. Dis. 13, 896-898.
62. Koo, G. C., and Gan, Y. H. (2006). The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol. 7:19. doi: 10.1186/1471-2172-7-19
63. Liu, B., Koo, G. C., Yap, E. H., Chua, K. L., and Gan, Y. H. (2002). Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect. Immun. 70, 504-511.
64. Mack, K., and Titball, R. W. (1996). Transformation of Burkholderia pseudomallei by electroporation. Anal. Biochem. 242, 73-76.
65. Matthysse, A. G., Yarnall, H. A., and Young, N. (1996). Requirement for genes with homology to ABC transport systems for attachment and virulence of Agrobacterium tumefaciens. J. Bacteriol. 178, 5302-5308.
66. Nelson, M., Prior, J. L., Lever, M. S., Jones, H. E., Atkins, T. P., and Titball, R. W. (2004). Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J. Med. Microbiol. 53, 1177-1182.
67. Ngauy, V., Lemeshev, Y., Sadkowski, L., and Crawford, G. (2005). Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War, I. I. J. Clin. Microbiol. 43, 970-972.
68. Ngugi, S. A., Ventura, V. V., Qazi, O., Harding, S. V., Kitto, G. B., Estes, D. M., et al. (2010). Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Vaccine 28, 7551-7555.
69. Nierman, W. C., Deshazer, D., Kim, H. S., Tettelin, H., Nelson, K. E., Feldblyum, T., et al. (2004). Structural flexibility in the Burkholderia mallei genome. Proc. Natl. Acad. Sci. U.S.A. 101, 14246-14251.
70. Nieves, W., Asakrah, S., Qazi, O., Brown, K. A., Kurtz, J., Aucoin, D. P., et al. (2011). A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 29, 8381-8389.
71. Nieves, W., Heang, J., Asakrah, S., Honer Zu Bentrup, K., Roy, C. J., and Morici, L. A. (2010). Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS ONE 5:e14361. doi: 10.1371/journal.pone.0014361
72. Owen, S. J., Batzloff, M., Chehrehasa, F., Meedeniya, A., Casart, Y., Logue, C. A., et al. (2009). Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J. Infect. Dis. 199, 1761-1770.
73. Peacock, S. J. (2006). Melioidosis. Curr. Opin. Infect. Dis. 19, 421-428.
74. Perry, M. B., Maclean, L. L., Schollaardt, T., Bryan, L. E., and Ho, M. (1995). Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun. 63, 3348-3352.
75. Pilatz, S., Breitbach, K., Hein, N., Fehlhaber, B., Schulze, J., Brenneke, B., et al. (2006). Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect. Immun. 74, 3576-3586.
76. Propst, K. L., Mima, T., Choi, K. H., Dow, S. W., and Schweizer, H. P. (2010). A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect. Immun. 78, 3136-3143.
77. Reckseidler, S. L., Deshazer, D., Sokol, P. A., and Woods, D. E. (2001). Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect. Immun. 69, 34-44.
78. Rosenbloom, M., Leikin, J. B., Vogel, S. N., and Chaudry, Z. A. (2002). Biological and chemical agents: a brief synopsis. Am. J. Ther. 9, 5-14.
79. Rowland, C. A., Lertmemongkolchai, G., Bancroft, A., Haque, A., Lever, M. S., Griffin, K. F., et al. (2006). Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect. Immun. 74, 5333-5340.
80. Rowland, C. A., Lever, M. S., Griffin, K. F., Bancroft, G. J., and Lukaszewski, R. A. (2010). Protective cellular responses to Burkholderia mallei infection. Microbes Infect. 12, 846-853.
81. Santanirand, P., Harley, V. S., Dance, D. A., Drasar, B. S., and Bancroft, G. J. (1999). Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67, 3593-3600.
82. Sarkar-Tyson, M., Smither, S. J., Harding, S. V., Atkins, T. P., and Titball, R. W. (2009). Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Vaccine 27, 4447-4451.
83. Sarkar-Tyson, M., Thwaite, J. E., Harding, S. V., Smither, S. J., Oyston, P. C., Atkins, T. P., et al. (2007). Polysaccharides and virulence of Burkholderia pseudomallei. J. Med. Microbiol. 56, 1005-1010.
84. Schell, M. A., Ulrich, R. L., Ribot, W. J., Brueggemann, E. E., Hines, H. B., Chen, D., et al. (2007). Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol. Microbiol. 64, 1466-1485.
85. Schell, M. A., Zhao, P., and Wells, L. (2011). Outer membrane proteome of Burkholderia pseudomallei and Burkholderia mallei from diverse growth conditions. J. Proteome Res. 10, 2417-2424.
86. Shah, P., and Swiatlo, E. (2006). Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae. Infect. Immun. 74, 5888-5892.
87. Srilunchang, T., Proungvitaya, T., Wongratanacheewin, S., Strugnell, R., and Homchampa, P. (2009). Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2. Southeast Asian J. Trop. Med. Public Health 40, 123-130.
88. Srinivasan, A., Kraus, C. N., Deshazer, D., Becker, P. M., Dick, J. D., Spacek, L., et al. (2001). Glanders in a military research microbiologist. N. Engl. J. Med. 345, 256-258.
89. Stevens, J. M., Ulrich, R. L., Taylor, L. A., Wood, M. W., Deshazer, D., Stevens, M. P., et al. (2005a). Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J. Bacteriol. 187, 7857-7862.
90. Stevens, M. P., Stevens, J. M., Jeng, R. L., Taylor, L. A., Wood, M. W., Hawes, P., et al. (2005b). Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol. Microbiol. 56, 40-53.
91. Stevens, M. P., Haque, A., Atkins, T., Hill, J., Wood, M. W., Easton, A., et al. (2004). Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150, 2669-2676.
92. Stevens, M. P., Wood, M. W., Taylor, L. A., Monaghan, P., Hawes, P., Jones, P. W., et al. (2002). An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol. Microbiol. 46, 649-659.
93. Su, Y. C., Wan, K. L., Mohamed, R., and Nathan, S. (2010). Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Vaccine 28, 5005-5011.
94. Sun, G. W., Lu, J., Pervaiz, S., Cao, W. P., and Gan, Y. H. (2005). Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cell. Microbiol. 7, 1447-1458.
95. Suputtamongkol, Y., Kwiatkowski, D., Dance, D. A., Chaowagul, W., and White, N. J. (1992). Tumor necrosis factor in septicemic melioidosis. J. Infect. Dis. 165, 561-564.
96. Tanabe, M., Atkins, H. S., Harland, D. N., Elvin, S. J., Stagg, A. J., Mirza, O., et al. (2006). The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect. Immun. 74, 3687-3691.
97. Tiyawisutsri, R., Holden, M. T., Tumapa, S., Rengpipat, S., Clarke, S. R., Foster, S. J., et al. (2007). Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. BMC Microbiol. 7:19. doi: 10.1186/1471-2180-7-19
98. Trevino, S. R., Permenter, A. R., England, M. J., Parthasarathy, N., Gibbs, P. H., Waag, D. M., et al. (2006). Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect. Immun. 74, 1958-1961.
99. Tuanyok, A., Stone, J. K., Mayo, M., Kaestli, M., Gruendike, J., Georgia, S., et al. (2012). The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl. Trop. Dis. 6:e1453. doi: 10.1371/journal.pntd.0001453
100. Ulett, G. C., Ketheesan, N., and Hirst, R. G. (2000). Proinflammatory cytokine mRNA responses in experimental Burkholderia pseudomallei infection in mice. Acta Trop. 74, 229-234.
101. Ulrich, R. L., Amemiya, K., Waag, D. M., Roy, C. J., and Deshazer, D. (2005). Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Vaccine 23, 1986-1992.
102. Ulrich, R. L., Deshazer, D., Hines, H. B., and Jeddeloh, J. A. (2004). Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect. Immun. 72, 6589-6596.
103. Utaisincharoen, P., Anuntagool, N., Arjcharoen, S., Limposuwan, K., Chaisuriya, P., and Sirisinha, S. (2004). Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages. Clin. Exp. Immunol. 136, 277-283.
104. Vasu, C., Vadivelu, J., and Puthucheary, S. D. (2003). The humoral immune response in melioidosis patients during therapy. Infection 31, 24-30.
105. Ventura, G. M., Balloy, V., Ramphal, R., Khun, H., Huerre, M., Ryffel, B., et al. (2009). Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia. J. Immunol. 183, 670-676.
106. Waag, D. M., England, M. J., and Deshazer, D. (2012). Humoral immune responses in a human case of glanders. Clin. Vaccine Immunol. 19, 814-816.
107. Wajanarogana, S., Sonthayanon, P., Wuthiekanun, V., Panyim, S., Simpson, A. J., and Tungpradabkul, S. (1999). Stable marker on flagellin gene sequences related to arabinose non-assimilating pathogenic Burkholderia pseudomallei. Microbiol. Immunol. 43, 995-1001.
108. Warawa, J., and Woods, D. E. (2002). Melioidosis vaccines. Expert Rev. Vaccines 1, 477-482.
109. Warawa, J., and Woods, D. E. (2005). Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model. FEMS Microbiol. Lett. 242, 101-108.
110. Warawa, J. M., Long, D., Rosenke, R., Gardner, D., and Gherardini, F. C. (2009). Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis. Infect. Immun. 77, 5252-5261.
111. West, T. E., Chierakul, W., Chantratita, N., Limmathurotsakul, D., Wuthiekanun, V., Emond, M. J., et al. (2012). Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis. Genes Immun. 13, 38-46.
112. West, T. E., Ernst, R. K., Jansson-Hutson, M. J., and Skerrett, S. J. (2008). Activation of Toll-like receptors by Burkholderia pseudomallei. BMC Immunol. 9:46. doi: 10.1186/1471-2172-9-46
113. White, N. J. (2003). Melioidosis. Lancet 361, 1715-1722.
114. Whitehead, N. A., Barnard, A. M., Slater, H., Simpson, N. J., and Salmond, G. P. (2001). Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25, 365-404.
115. Whitlock, G. C., Deeraksa, A., Qazi, O., Judy, B. M., Taylor, K., Propst, K. L., et al. (2010). Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. Procedia Vaccinol. 2, 73-77.
116. Whitlock, G. C., Lukaszewski, R. A., Judy, B. M., Paessler, S., Torres, A. G., and Estes, D. M. (2008). Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei. BMC Immunol. 9:55. doi: 10.1186/1471-2172-9-55
117. Whitlock, G. C., Robida, M. D., Judy, B. M., Qazi, O., Brown, K. A., Deeraksa, A., et al. (2011). Protective antigens against glanders identified by expression library immunization. Front. Microbiol. 2:227. doi: 10.3389/fmicb.2011.00227
118. Wiersinga, W. J., Dessing, M. C., Kager, P. A., Cheng, A. C., Limmathurotsakul, D., Day, N. P., et al. (2007a). High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect. Immun. 75, 3074-3079.
119. Wiersinga, W. J., Wieland, C. W., Dessing, M. C., Chantratita, N., Cheng, A. C., Limmathurotsakul, D., et al. (2007b). Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 4:e248. doi: 10.1371/journal.pmed.0040248
120. Wiersinga, W. J., Wieland, C. W., Van Der Windt, G. J., De Boer, A., Florquin, S., Dondorp, A., et al. (2007c). Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect. Immun. 75, 3739-3746.
121. Wiersinga, W. J., and Van Der Poll, T. (2009). Burkholderia pseudomallei tropism and the melioidosis road map. J. Infect. Dis. 199, 1720-1722.
122. Wiersinga, W. J., Wieland, C. W., Roelofs, J. J., and Van Der Poll, T. (2008). MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS ONE 3:e3494. doi: 10.1371/journal.pone.0003494
123. Yakushi, T., Masuda, K., Narita, S., Matsuyama, S., and Tokuda, H. (2000). A new ABC transporter mediating the detachment of lipid-modified proteins from membranes. Nat. Cell Biol. 2, 212-218.
124. Zhang, S., Feng, S. H., Li, B., Kim, H. Y., Rodriguez, J., Tsai, S., et al. (2011). In vitro and In vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei. Clin. Vaccine Immunol. 18, 825-834.